This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Exploring EMBLAVEO, A Breakthrough FDA-Approved Treatment for Complicated Intra-Abdominal Infections and Antimicrobial Resistance

Ticker(s): ABBV

Who's the expert?

Institution: BTMAInfectious disease consultant at a private practice in community hospital in NJ

  • CoChair of Antimicrobial Stewardship program and chair of Sepsis committee
  • Experience with Clinical research and specifically,immunomodulators for viral infections, vaccines, anti infectives 

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.